Speakers' List
- Geoffrey Coombs
- Murdoch University, Australia
- S1-1. Unique Evolution of CA-MRSA Clones
- Doo-Ryeon Chung
- Samsung Medical Center, Korea
- S1-2. CA-MRSA as a new nosocomial pathogen
- Robert Daum
- The University of Chicago, USA
- S1-3. A vaccine for Staphylococcus aureus?
- Ian Gould
- NHS Grampian, UK
- S1-4. Treatment options for CA-MRSA infections
- Hyuk-Joon Kwon
- Seoul National University, Korea
- S2-1. Recent highly pathogenic avian influenza outbreaks by H5N6 and H5N8 viruses and molecular risk assessment of mammalian pathogenicity
- Nam-Hyuk Cho
- Seoul National University College of Medicine, Korea
- S2-2. Virological and immunological responses in MERS patients
- Masayuki Saijo
- National Institute of Infectious Diseases, Japan
- S2-3. Clinical, epidemiological, and virological aspects of SFTS in Japan: what we have learned and what we should do?
- Michael Osterholm
- University of Minnesota, USA
- S2-4. Infectious Diseases in the 21st Century: A Battle Plan for Survival
- Po-Ren Hsueh
- National Taiwan University Hospital, Chinese Taipei
- S3-1. Colistin resistance in gram-negatives
- Eun-Jeong Yoon
- Research Institute of Bacterial Resistance, Korea
- S3-2. Emergence of mcr-1 colistin resistance: a new story begins
- Yohei Doi
- University of Pittsburgh, USA
- S3-3. What to use in the clinical practice?
- Anucha Apisarnthanarak
- Thammasat University Hospital, Thailand
- S3-4. Colistin resistance: is it preventable?
- S7-3. Active surveillance based on MDR gram-negative pathogens?
- David Livermore
- University of East Anglia, UK
- S4-1. Carbapenemases from KPC to NDM to OXA-48: diverse enzymes in diverse clones
- Kyungwon Lee
- Yonsei University College of Medicine, Korea
- S4-2. Diagnostic challenges in detecting carbapenem resistance
- Ami Neuberger
- Rambam Medical Center, Israel
- S4-3. Antimicrobial treatment; recommendation and options for carbapenem-resistant Enterobacteriaceae
- Linfa Wang
- Duke-NUS Medical School, Singapore
- S5-1. One Health lessons from investigation emerging viruses of bat origin
- Yong Ho Park
- Seoul National University, Korea
- S5-2. One health approaches to zoonotic diseases and AMR
- John Clemens
- International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh
- S5-3 One health activities on Nipah in Bangladesh: a high risk country for zoonotic disease spillover to man
- Cheng-Hsun Chiu
- Chang Gung Children's Hospital, Chinese Taipei
- S6-1. Mycoplasma pneumoniae Infection in Children
- Eun Hwa Choi
- Seoul National University College of Medicine, Korea
- S6-2. Macrolide-resistant Mycoplasma pneumoniae pneumonia in children
- Nancy Henry
- Mayo Clinic, USA
- S6-3. Management of severe mycoplasma infection :
role of antibiotics and steroid
- Stephan Harbarth
- Geneva University Hospitals, Switzerland
- S7-1. Knowledge gaps in hand hygiene monitoring and efficacy
- Eun Ju Choo
- Soonchunhyang University Hospital, Korea
- S7-2. Fight against healthcare-borne flavivirus named HCV
- Young Hwa Choi
- Ajou University Hospital, Korea
- S7-4. Ten-year experience of KONIS
- Jong Hee Shin
- Chonnam National University School of Medicine, Korea
- S8-1. Diagnosis of fungal infections: current status
- Thomas Patterson
- UT Health San Antonio
- S8-2. The newest treatment strategies for candidemia
- Sharon Chen
- University of Sydney, Australia
-
S8-3. Epidemiology and approach to management to invasive aspergillosis and mucormycosis
- Louis Chai
- National University Health System, Singapore
- S8-4. Endemic fungal infection in the Asia-Pacific region (in the context of altered immunity)
- Rossana Ditangco
- Research Institute for Tropical Medicine, Philippines
- S9-1. Preexposure prophylaxis: from science to implementation
- Shuzo Matsushita
- Center for AIDS Research/ Kumamoto University, Japan
- S9-2. Broadly neutralizing antibody for treatment and prevention of HIV infection
- Hyongbum Kim
- Yonsei University College of Medicine, Korea
- S9-3. Genome editing using programmable nucleases including CRISPR-Cas
- Shui Shan Lee
- The Chinese University of Hong Kong, Hong Kong, China
- S9-4. Achievability of HIV treatment as prevention
- Wang Hui
- Peking University People's Hospital, PR China
- S10-1. Epidemiology of extensively-resistant Gram-negative in Mainland China
- Justin O'Grady
- University of East Anglia, UK
- S10-2. Improving the diagnosis and management of serious infection using rapid point-of-care metagenomic sequencing
- Robin Patel
- Mayo Clinic, USA
- S10-3. NGS for infectious disease diagnosis and surveillance
- Sunghoon Kim
- Seoul National University /
Medicinal Bioconvergence Research Center, Korea
- S11-1. Protein Synthesis Enzymes as Primary Defense System against Infection
- Jung-Hyun Choi
- Incheon St Mary's Hosp. The Catholic University of Korea, Korea
- S11-2. Resuscitation in sepsis: reexamining the paradigm
- Jaroslaw Zmijewski
- University of Alabama at Birmingham, USA
- S11-3. New therapeutic targets for sepsis: better late than never
- Victor Lim
- International Medical University, Malaysia
- S12-1. The role of Behavioural Sciences in Antibiotic Stewardship
- David Lye
- Tan Tock Seng Hospital, Singapore
- S12-2. Impact of ASP program on reducing AMR in the hospitals
- Jacob Lee
- Hallym University Kangnam Sacred Heart Hospital, Korea
- S12-3. Computer decision support and surveillance systems for ASP